Meet with BIOVECTRA at Meeting on the Mesa 2024
Phoenix, Arizona | October 7-9, 2024
Schedule a meeting with us at this year's Cell and Gene Meeting on the Mesa and discover how BIOVECTRA can help with your mRNA manufacturing needs.
BIOVECTRA's state-of-the-art Biomanufacturing and Vaccine Center has the:
- Capability to develop and manufacture plasmid DNA, mRNA, LNP formulations, and fill/finish
- With scales ranging from mL to 30L, we have the ability to produce up to 160 million doses of mRNA vaccines per year
- Capacity to prepare and package 70 million fill/finish doses per year for commercial distribution
BIOVECTRA is a North American CDMO specializing in the clinical-to-commercial scale production of high-quality regulated APIs and intermediates, including:
- Custom lipids
- Biologics
- pDNA, mRNA, LNP manufacturing
- Synthetic small molecules
- Fermented small molecules
- Highly potent APIs
- Bioreagents
- Fill/Finish
Our team – backed by 50+ years of experience – looks forward to the opportunity to put our flexible, innovative manufacturing solutions at your disposal.
|
Schedule a meeting with us and discover how we can support your
projects and solve your most complex challenges.
|
